Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Neoplasms Malignant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT01543620
What this trial is testing

Prospective Observational Study to Evaluate Biomarkers of Aminoglycoside Nephrotoxicity in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Foundation for the National Institutes of Health 150
Not applicableActive Not RecruitingNCT04258813
What this trial is testing

Onco-primary Care Networking to Support TEAM-based Care

Who this might be right for
Blood PressureHypertensionCancer+15 more
Duke University 313
Not applicableUnknownNCT04158414
What this trial is testing

Applying PET/MR in Oncology - a Prospective Project

Who this might be right for
LymphomaNasopharyngeal CancerEsophageal Cancer+5 more
Tel-Aviv Sourasky Medical Center 500
Early research (Phase 1)Looking for participantsNCT04890613
What this trial is testing

Study of CX-5461 in Patients With Solid Tumours and BRCA1/2, PALB2 or Homologous Recombination Deficiency (HRD) Mutation

Who this might be right for
Advanced Solid Tumor
Senhwa Biosciences, Inc. 52
Not applicableLooking for participantsNCT05663515
What this trial is testing

A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

Who this might be right for
Pancreatic Cancer
AstraZeneca 24,000
Large-scale testing (Phase 3)Study completedNCT00057876
What this trial is testing

Gemcitabine With or Without Radiation Therapy in Treating Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group 74
Not applicableUnknownNCT04148755
What this trial is testing

The Accurateness of Endoscopic Ultrasound Elastography in the Guidance of EUS-FNA in Solid Pancreatic Lesions

Who this might be right for
Pancreatic Cancer
Assiut University 100
Not applicableWithdrawnNCT06054308
What this trial is testing

Mesothelin-targeted CAR-T Cells as a Neo-adjuvant Treatment in Patients With Resectable Pancreatic Cancers: a Feasibility Study

Who this might be right for
Pancreatic Cancer
Chinese University of Hong Kong
Testing effectiveness (Phase 2)Active Not RecruitingNCT01088789
What this trial is testing

Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 71
Testing effectiveness (Phase 2)Study completedNCT00497224
What this trial is testing

Phase II Trial of Erlotinib in Advanced Pancreatic Cancer

Who this might be right for
CancerPancreas
University Health Network, Toronto 51
Testing effectiveness (Phase 2)Ended earlyNCT01116791
What this trial is testing

Cytoreductive Surgery(CRS) Plus Hyperthermic Intraoperative Peritoneal Chemotherapy(HIPC) With Cisplatin to Treat Peritoneal Carcinomatosis From Upper Gastrointestinal Cancer

Who this might be right for
Peritoneal CarcinomatosisGastrointestinal Cancer
Baki Topal 34
Not applicableStudy completedNCT05395013
What this trial is testing

Efficacy and Safety of Plastic, Covered and Uncovered Self-expandable Metal Stents in the Treatment of Malignant Biliary Obstructions (NEOSTENT)

Who this might be right for
Common Bile Duct StrictureJaundice; Malignant
Azienda Unità Sanitaria Locale della Romagna 3,149
Early research (Phase 1)Study completedNCT06378047
What this trial is testing

Irreversible Electroporation & Pembro Immunotherapy in Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic CancerLocally Advanced Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 2
Testing effectiveness (Phase 2)Looking for participantsNCT05241249
What this trial is testing

Stimulation With Bethanechol in Combination With Gemcitabine and Nab-paclitaxel in Pancreatic Adenocarcinoma

Who this might be right for
Pancreas Cancer
Susan E. Bates 37
Testing effectiveness (Phase 2)Looking for participantsNCT02598349
What this trial is testing

Proton Radiation for Unresectable, Borderline Resectable, or Medically Inoperable Carcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Proton Collaborative Group 60
Testing effectiveness (Phase 2)Looking for participantsNCT06423326
What this trial is testing

Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer

Who this might be right for
Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more
Emory University 36
Testing effectiveness (Phase 2)Ended earlyNCT01851174
What this trial is testing

Study to Evaluate Bi-weekly Dosing of Gemcitabine Plus Nab-Paclitaxel to Treat Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma Non-resectableStage IV Pancreatic Cancer
Western Regional Medical Center 15
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Study completedNCT00965718
What this trial is testing

Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GC Cell Corporation 20
Not applicableEnded earlyNCT00899132
What this trial is testing

Studying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer

Who this might be right for
Non-melanomatous Skin CancerPancreatic CancerSmall Intestine Cancer+1 more
Case Comprehensive Cancer Center 180
Next Page